For research use only. Not for therapeutic Use.
IRAK4-IN-4 (CAT: I017648) represents an inhibitor targeting interleukin-1 receptor-associated kinase 4 (IRAK4), a critical enzyme involved in innate immune signaling. By selectively inhibiting IRAK4, this compound disrupts signaling pathways triggered by immune receptors, dampening the inflammatory response. Such inhibition is crucial in managing immune-related disorders, including autoimmune diseases and inflammatory conditions.
Catalog Number | I017648 |
CAS Number | 1850276-58-2 |
Molecular Formula | C₂₂H₁₆N₂O₂ |
Purity | ≥95% |
Target | IRAK |
Reference | [1]. One class has the naphthalene second dione compounds and its derivative of protease modification activities. CN107163044A. |